Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMNN
IMNN logo

IMNN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Imunon Inc (IMNN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.910
1 Day change
1.60%
52 Week Range
13.430
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Imunon Inc (IMNN) is not a strong buy at the moment for a long-term beginner investor with $50,000-$100,000 available. The technical indicators show bearish momentum, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. While the stock is oversold based on RSI, the lack of strong financial data, recent news, or significant institutional or insider activity makes it prudent to hold off on investing right now.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. The RSI is extremely low at 12.822, signaling an oversold condition. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. Key support is at 1.836, and resistance is at 2.126. Overall, the technical outlook is bearish.

Positive Catalysts

  • The stock is oversold based on RSI, which could indicate a potential rebound in the short term. Analysts have initiated coverage with a Buy rating and a $10 price target.

Neutral/Negative Catalysts

  • Bearish technical indicators, lack of recent news, no significant insider or hedge fund activity, and no recent congress trading data. The stock has shown a regular market decline of -2.15% and a pre-market decline of -1.08%.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Maxim initiated coverage with a Buy rating and a $10 price target, which is significantly higher than the current price. However, this is the only analyst rating available, and no recent updates are provided.

Wall Street analysts forecast IMNN stock price to rise
1 Analyst Rating
Wall Street analysts forecast IMNN stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.880
sliders
Low
12
Averages
12
High
12
Current: 1.880
sliders
Low
12
Averages
12
High
12
Maxim
Buy
initiated
$10
AI Analysis
2026-04-17
Reason
Maxim
Price Target
$10
AI Analysis
2026-04-17
initiated
Buy
Reason
Maxim initiated coverage of Imunon with a Buy rating and $10 price target.

People Also Watch